APTAMERS: THERAPEUTICS, TECHNOLOGIES, AND SERVICES MARKET

Aptamers have gained a lot of momentum in the past decade. It is worth highlighting that in 2005, Macugen became the first and the only USFDA approved aptamer drug for treating age-related macular degeneration (AMD).

For additional details, please visit:- https://www.rootsanalysis.com/....reports/aptamers-the or email sales@rootsanalysis.com